Assessment of potential predictive value o f peripheral blood inflammatory indexes in 26 cases with soft tissue sarcoma treated by pazopanib: a retrospective study


MİRİLİ C. , Payday S., GÜNEY İ. B. , OĞUL A. , GÖKÇAY S. , BÜYÜKŞİMŞEK M. , ...More

CANCER MANAGEMENT AND RESEARCH, vol.11, pp.3445-3453, 2019 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 11
  • Publication Date: 2019
  • Doi Number: 10.2147/cmar.s191199
  • Title of Journal : CANCER MANAGEMENT AND RESEARCH
  • Page Numbers: pp.3445-3453
  • Keywords: soft tissue sarcoma, STS, pazopanib, angiogenesis, inflammation, neutrophil-to-lymphocyte ratio, NLR, derived neutrophil-to-lymphocyte ratio, DNLR, PROGNOSTIC-FACTORS, LYMPHOCYTE RATIO, CANCER, ANGIOGENESIS, BIOMARKERS, NEUTROPHIL, SURVIVAL, MONOCYTE

Abstract

Purpose: The aim of this study was to evaluate the prognostic and predictive value o f neutrophilto-lymphocyte ratio (NLR), derived neutrophil-to-lymphocyte ratio (DNLR), lymphocyte-tomonocyte ratio (LMR), and platelet-to-lymphocyte ratio (PLR) in soft tissue sarcoma (STS) cases treated with pazopanib.